跳至主要内容
临床试验/CTRI/2019/05/019211
CTRI/2019/05/019211尚未招募4 期

CVD, inflammation and bone metabolism markers in CKD: Feasibility study of a multi-centric, randomized trial of cholecalciferol supplementation

Department of Biotechnology Government of India0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age 18-75 years
  • 2. eGFR by CKD-EPI 10-45 ml/min/1.73m2
  • 3. Serum 25(OH)D levels 20-50 ng/ml
  • 4. Clinically stable course as judged by the treating physician for last 3 months

排除标准

  • 1. Receiving long-term maintenance dialysis
  • 2. Receiving immunosuppressive therapy
  • 3. Diagnosis of chronic liver disease
  • 4. Diagnosis of primary hyperparathyroidism
  • 5. Diagnosis of sarcoidosis
  • 6. History of having been treated for hypercalcemia due to any cause
  • 7. Anticipated to need long-term renal replacement therapy within 6 months as judged by
  • treating physician
  • 8. Poor functional status as judged by the treating physician
  • 9. Life expectancy <1 year as judged by the treating physician
  • 10. Pregnancy in case of females
  • 11. Blood Hemoglobin <8 g/dL
  • 12. Serum calcium >9.5 mg/dL
  • 13. History of having received any type of organ transplant
  • 14. Diagnosis of malignancy
  • 15. History of allergy to the interventional drugs (cholecalciferol)
  • 16. Having received vitamin D supplementation in last 30 days

研究者

相似试验